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Proteomic analysis of mitochondria in
APOE transgenic mice and in response
to an ischemic challenge
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Catherine M Gliddon1, Joanne Povey1,3, Ruth F Deighton1, Lorraine E Kerr2,
James McCulloch1 and Karen Horsburgh1
1Centre for Cognitive Aging and Cognitive Epidemiology, Centre for Cognitive and Neural Systems,
School of Biomedical Sciences, University of Edinburgh, Edinburgh, UK; 2Centre for Systems Biology
at Edinburgh, University of Edinburgh, Edinburgh, UK; 3Department of Anatomy and Structural Biology,
University of Otago, Dunedin, New Zealand
Apolipoprotein E (APOE)-e4 is associated with a deleterious outcome after ischemic brain injury,
which may involve abnormal regulation of mitochondrial function. We have assessed the
mitochondrial proteomic response of APOE-e3 and APOE-e4 transgenic mice to transient global
ischemic injury in the hippocampus. A genotype-dependent increase in ApoE levels in mitochondria
was observed after ischemia, with APOE-e4 mice showing significantly greater increases than
APOE-e3 mice. Quantitative analysis of the mitochondria-enriched fractions was performed using
liquid-chromatography mass spectrometry coupled to label-free analysis. Of the 1,067 identified
proteins, 274 were mitochondria associated. Mitochondrial protein expression was significantly
different between genotypes under basal conditions as well as in response to global ischemia.
A total of 12 mitochondrial proteins (including respiratory chain proteins NDUFA11, NDUFS3,
NDUF5B, ATP5J, as well as ETFA, CYB5B, ATP6V1A, HSPA1B, OXR1, GLUL, IARS2, and PHYHIPL)
were significantly altered with respect to genotype, global ischemia, or their interaction (P<0.01).
A compelling interactome, created using proteins found to be significantly modulated by global
ischemia (P<0.05), involved proteins that regulate energy production and oxidative stress. Thus,
APOE genotype has a differential effect on the mitochondrial protein expression in the absence and
presence of an injury, which may underlie the differing genotype susceptibility.
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Introduction
Of the different forms of apolipoprotein E (ApoE 2, 3,
and 4), ApoE4 has a deleterious role in ischemic
brain injury and is associated with a worse response
and poorer long-term outcome in response to acute
focal ischemic stroke, transient global ischemia,
and hemorrhage (Horsburgh et al, 2000a, b; Sheng
et al, 1998). Possession of an APOE-e4 allele is also
associated with a deleterious influence on cognitive
aging and is the major genetic risk factor for
Alzheimer’s disease (Saunders et al, 1993). Although
the underlying mechanism for the deleterious
effect of ApoE4 is not yet known, there are strong
links between ApoE4 and mitochondrial dysfunction
that might explain a general influence of ApoE4 on
injury and disease. Mitochondria are critical in
regulating normal neuronal functions and are dis-
rupted in injury and disease (Mattson et al, 2008),
often influenced by the presence of APOE-e4.
Notably, one of the earliest features detectable in
the brains of young and elderly APOE-e4 individuals
(de Leon et al, 2001) is regional cerebral hypometa-
bolism, a reflection of reduced mitochondrial
function. This regional hypometabolism is further
exacerbated in disease in APOE-e4 carriers (Mielke
et al, 1998). Transgenic APOE-e4 mice also exhibit
structural (Shenk et al, 2009) and functional (Strum
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et al, 2007; Choi et al, 2004) mitochondrial abnorm-
alities. It has also been shown that there are
structural and subsequent biophysical differences
between ApoE protein isoforms, which may explain
differential influences on mitochondrial function
(Huang et al, 2004). The structural conformation of
ApoE4 ensures more efficient neuronal proteolytic
cleavage compared with ApoE2 or ApoE3 with
generated ApoE4 fragments causing neurodegenera-
tion and cognitive deficits in transgenic mice
(Harris et al, 2003). There is direct evidence from
in vitro cell-culture studies that overexpression of a
truncated ApoE4 fragment, localizes to mitochondria
and impairs mitochondrial function (Chang et al,
2005). Similarly, a number of mitochondrial proteins
have been identified as ApoE4-binding partners
from cytosolic and membrane fractions of mouse
brain (Nakamura et al, 2009). Thus, ApoE isoforms
may have differential effects on mitochondrial func-
tion that, in the presence of ApoE4, could render
mitochondria susceptible to the effects of brain
injury.
At present, the protein signature of mitochondria
in different APOE genotypes is not known and is
important as it could provide a basis on which to
further explore biological differences between the
different ApoE isoforms. To address this, we used
liquid-chromatography mass spectrometry (LC-MS),
which permits the quantitative assessment of large
numbers of proteins simultaneously in brain tissue
samples, and obtained a measure of mitochondrial
proteins at baseline and in response to an ischemic
challenge in APOE-e3 and APOE-e4 transgenic mice.
The data demonstrate that not only is the protein
signature different between ApoE isoforms at basal
conditions but that there is a differential response of
these proteins in response to injury.
Materials and methods
APOE Transgenic Mice
APOE-e3 and APOE-e4 transgenic mice were produced as
described previously (Xu et al, 1996). Briefly, APOE
knockout mice were generated by inactivating the endo-
genous APOE gene. Cosmid libraries were constructed
from lymphoblasts of humans who were homozygous for
APOE-e3 and APOE-e4. Fragments containing human
regulatory sequences and the coding sequences for
human APOE (e3 and e4) were isolated and injected into
single-cell embryos from homozygous APOE-deficient
mice and transferred to female recipients (a cross of
C57BL/6JDBA/2J) to produce founder transgenic mice.
Founder mice were backbred to APOE knockout mice to
produce mice hemizygous for human APOE transgenes and
homozygous for inactivated mouse APOE gene. Animals
were bred to homozygosity for human APOE transgenes
and backbred into APOE knockout strains to remove
the genetic influence of DBA/2J background strains. The
presence of human APOE was confirmed by PCR. The mice
were backcrossed at least 10 times to C57BL/6J mice in the
USA before transport to Edinburgh, UK and thereafter
several backcrosses to C57BL/6J were made. For the
present study, the APOE-e3-437 and APOE-e4-81 lines
were used, which carry two copies of the respective
transgenes and are best matched for ApoE levels from the
original lines bred (Xu et al, 1996). All procedures
were authorized under the Home Office approved project
license number 60/3722. This license was approved by
the University of Edinburgh’s Ethical Review Committee
and the Home Office and adhered to regulations
specified in the Animals (Scientific Procedures) Act
(1986). Mouse genotype was confirmed by PCR (Horsburgh
et al, 2000b).
Transient Global Ischemia
Adult, male mice were initially anesthetized with 5%
isofluorane with oxygen, and maintained in 1.5% isofluor-
ane. Temperature was monitored using a rectal probe and
controlled to 37±0.51C. A midline cervical incision
was made and both common carotid arteries exposed
and isolated using 4/0 silk thread. The common carotid
arteries were occluded using microaneurysm clips applied
bilaterally for 20minutes. The duration of ischemia was
based on previous observations, indicating that this
duration was sufficient to induce ischemic neuronal
damage in the caudate nucleus (Horsburgh et al, 2000b;
Kelly et al, 2001). After the period of occlusion, the clips
were removed and blood flow through the arteries was
confirmed before the incision was sutured closed (n=9,
APOE-e3 mice; n=9, APOE-e4 mice). Sham-operated
animals underwent an identical procedure except clips
were not applied to the common carotid arteries (n=5,
APOE-e3 mice; n=6, APOE-e4). The animals were placed
in an incubator for 1hour after which they were returned to
the animal housing and allowed to recover. At 72hours
after treatment, the animals were deeply anesthetized
with 5% isofluorane with oxygen, and perfused trans-
cardially with buffered saline and the brain removed
and halved. One hemisphere was fixed using 4% para-
formaldehyde and then paraffin embedded for histological
analyses. From the other hemisphere, the hippocampus
was dissected out and used to prepare mitochondrial
fractions. At the outset of the study, mice were coded and
randomized for surgery with the operator blind to the
genotype of the mice. The study was conducted with a
priori hypothesis.
Hematoxylin and Eosin Staining to Determine Ischemic
Damage
Paraffin-embedded sections (6mmol/L) were cut and
stained with hematoxylin and eosin. The numbers of
morphologically normal neurons and neurons showing
features of ischemic cell change, defined by intense
hematoxylin-stained pyknotic nuclei surrounded by eosi-
nophilic cytoplasm, were counted in five randomly
selected fields within the CA1 region of the hippocampus,
using a 1-cm2 grid at  400 magnification. The percentage
of ischemic neurons was calculated for the area of interest.
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Preparation of Mitochondrial Fractions
From each animal (n=29), mitochondrial fractions were
prepared from a single hippocampus. Mitochondria were
prepared from fresh tissue and all steps were performed on
ice. Mitochondrial fractions were prepared using the
Benchtop Mitochondria Isolation Kit for Rodent Tissue
(Mitosciences, Eugene, OR, USA), generating two fractions:
a mitochondrial fraction (M) and a postmitochondrial
supernatant fraction (PM). The mitochondrial fraction is
enriched in mitochondrial proteins, while the supernatant
fraction is predominantly cytosolic, containing soluble and
membrane-associated proteins. Protein concentrations of
the fractions were determined using Pierce BCA assay.
Immunoblotting and Antibody Detection
Proteins were separated by SDS–PAGE and transferred
onto PVDF membrane (GE Healthcare, Buckinghamshire,
UK). Immunoblotting was performed using the Odyssey
Infrared Imaging System (LiCor Biosciences, Lincoln, NE,
USA). Membranes were blocked in Odyssey blocking
buffer (diluted 1:1 with phosphate-buffered saline) and
washed in phosphate-buffered saline–Tween (phosphate-
buffered saline with 0.1% Tween). Primary antibodies were
detected using fluorescently labelled secondary antibodies
(LiCor Biosciences). Proteins were visualized by scanning
antibody-labelled blots in the Odyssey Imager under the
appropriate channel. Antibodies for western blotting were
obtained from relevant manufacturer’s: ApoE (Calbiochem,
Darmstadt, Germany), COXI (Mitosciences, Eugene, OR,
USA), COXIV (Cellular Signalling, Herfordshire, UK) and
VDAC1 (AbCam, Cambridge, UK).
Analysis of Proteins from Immunoblots
Quantification was performed using the Odyssey image
analysis program (LiCor Biosciences). In brief, the appro-
priate band was selected, background subtraction applied,
and a resulting optical density (OD) value computed.
To determine enrichment of mitochondrial markers
(VDAC1, COXI, and COXIV), OD intensities were obtained
from both mitochondrial and postmitochondrial fractions.
These were used to determine the percentage of each
protein in the mitochondrial fraction and allowed the
assessment of mitochondrial integrity. For ApoE quantifi-
cation, all raw OD values were normalized to recombinant
ApoE3 (Chemicon, Watford, UK), loaded to enable intergel
comparisons. This resulted in a normalized OD value
(norm OD) that was analyzed statistically.
Liquid-Chromatography Mass Spectrometry Analysis
of Mitochondria-Enriched Fractions
High-throughput proteomics using liquid chromatography in
tandem with mass spectrometry has emerged as a valuable
tool in understanding global protein expression without
prior knowledge of the studied system (for recent review, see
Nilsson et al, 2010). To examine the proteomic response in
APOE transgenic mice after ischemic injury, we conducted a
quantitative analysis of the mitochondria-enriched fractions
using a shotgun proteomic LC-MS approach coupled to a
label-free analysis using MaxQuant software.
Four groups were analyzed with the number of animals
within each group corresponding to that already examined
for ApoE levels (ApoE3 sham n=5, ApoE3 global ischemia
n=9; ApoE4 sham n=6, ApoE4 global ischemia n=9). All
chemicals were purchased from Sigma-Aldrich (Gillingham,
UK) unless otherwise stated. Acetonitrile and water for
LC-MS/MS were HPLC grade (Fisher, Loughborough,
UK). Formic acid was Suprapure 98% to 100% (Merck,
Darmstadt, Germany) and trifluoroacetic acid was 99%
purity sequencing grade. All HPLC-MS connector fittings
were from Upchurch Scientific or Valco (Hichrom, Theale,
UK and RESTEK, Saunderton, UK).
In all, 100mg of protein extract from mitochondrial
fractions was resuspended in 12.5 mL of 6mol/L urea,
2.5 mL of 200mmol/L DTT, 2.5 mL of 1mol/L ammonium
bicarbonate, and 1 mL of 5% CHAPS. The samples were
reduced at room temperature for 30minutes then 2.5mL of
500mmol/L iodoacetamide was added. Samples were
diluted to 50 mL, 2mg of trypsin was added and digested
overnight. A fraction of the tryptically digested samples
(10 mg) was cleaned using an in-house SCX column
(200 mm 6 cm) packed with 10 mm PolySulfoethyl (Poly
LC Inc., Columbia, MD, USA) as follows: SCX columns
were conditioned with 100mL of 10mmol/L potassium
phosphate buffer (KPB), pH 3. Tryptic digests (5 mL) were
diluted with 45 mL of 50mmol/L H3PO4, 10% acetonitrile
and loaded on the SCX column. SCX columns were
washed with 40mmol/L KPB, 10% acetonitrile and eluted
with 75 mL of 200mmol/L ammonium bicarbonate.
Capillary-HPLC-MSMS data were collected on an online
system consisting of a micropump (1,200 binary HPLC
system, Agilent, Edinburgh, UK) coupled to a hybrid LTQ-
Orbitrap XL instrument (Thermo-Fisher, Loughborough,
UK). The LTQ was controlled through Xcalibur 2.0.7 and
LTQ Orbitrap XL MS2.4SPI (Thermo-Fisher, Loughbor-
ough, UK). HPLC-MS methods have been described
previously (Le Bihan et al, 2010). Peptides were recon-
stituted in 10 mL of loading buffer before injection and
8 mL was loaded. The peptide mixture was separated using
a 2-hour gradient from 0% to 100% Buffer B (90%
acetonitrile, 10% H2O, 0.025% trifluoroacetic acid, and
0.1% formic acid).
The mass spectrometer was operated in ‘data-dependent
mode,’ with a single MS scan (400 to 2,000 m/z) in FT
mode 60K resolution followed by MS/MS scans in the
linear ion trap on the three most abundant ions and
dynamic excluded for 120 seconds.
Protein Identification and Quantification
Conversion from RAW to MGF files was performed as
described previously (Le Bihan et al, 2010). MS/MS data
were searched using MASCOT Versions 2.3 (Matrix
Science Ltd., London, UK) against a mouse plus contami-
nant IPI database with 55,413 sequences downloaded from
http://www.ebi.ac.uk (version v3.42) and amended with
the human ApoE and ApoE4 sequences due to the
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transgenic nature of the mouse model. Variable methionine
oxidation, STY phosphorylation, protein N-terminal acet-
ylation, and fixed cysteine carbamidomethylation were
used in all searches. Precursor mass tolerance was set to
7 p.p.m. and MS/MS tolerance to 0.4 a.m.u. The signifi-
cance threshold (P) was set < 0.05 (MudPIT scoring in
Mascot). All LC-MS runs were combined using MaxQuant
(version 1.0.13.8, Max Plank Institute of Biochemistry,
Martinsried, Germany), assuming a false positive rate of
0.01. The MaxQuant output of protein group intensities,
calculated as the sum of MS-peak intensities of identi-
fied peptides, was used as a relative abundance measure
between samples. The data were converted using the
Pride converter v2.4.2 (Barsnes et al, 2009) and are
available on the public data repository PRIDE (http://
www.ebi.ac.uk/pride/; project ‘Mouse APOE,’ accessions
15885 to 15913).
MaxQuant Label-Free Analysis Validation
The quantitation of relative protein abundance using
MaxQuant was validated by spiking alcohol dehydrogen-
ase (ADH Saccharomyces cerevisiae, Sigma, Gillingham,
UK) into 10mL HeLa cell extract (Dundee Cell, Dundee,
UK, see Le Bihan et al, 2010). Spiked samples were
analyzed back-to-back in 2-hour LC gradients. Three
unspiked samples were run at the start, middle, and end
of the queue to check for any carryover. The intensity of
ADH in the unspiked samples was zero, indicating no
carryover issues for ADH peptides. Spiked ADH concen-
trations were correlated with protein group intensities. A
linear fit showed a positive correlation of spiked concen-
tration with the protein group intensity computed by
MaxQuant, with an R2 value of 0.992 (see Figure 1). This
control experiment provides validation for the use of
MaxQuant as a label-free analysis tool for the results
presented below.
Bioinformatics Analysis
All proteins identified by LC-MS and Maxquant software
(version 1.0.13.8) by at least two or more peptides were
uploaded to the Database for Annotation, Visualization and
Integrated Discovery (DAVID) (http://david.abcc.ncifcrf.
gov; Huang da et al, 2009) to determine subcellular
localization based on gene ontology (GO). The experimen-
tal interest and focus for this study were changes in the
levels of mitochondrial proteins as a result of global
ischemia in the context of two different APOE genotypes.
Cognizant of the fact that mitochondrial preparations are
enriched in, but are not exclusively mitochondrial pro-
teins, proteins included in the GO term mitochondrion
(GO:0005739) were identified from the master list, filtered
out and subsequently analyzed statistically to determine
differences in expression levels for this select protein pool.
Statistical Analysis
Immunoblot data are presented as mean±s.e.m. Data were
analyzed using GraphPad Prism version 5 (GraphPad Soft-
ware Inc., La Jolla, CA, USA). Analysis of mitochondrial
marker enrichment and quantification of ApoE levels from
mitochondrial fractions were performed using two-way
analyses of variance (ANOVAs) to allow simultaneous
comparison between treatment groups (sham operated or
global ischemia) and genotype (APOE-e3 or APOE-e4). Post
hoc comparisons of two-way ANOVAs were made using
t-test with Bonferroni correction unless otherwise noted. A
value of P<0.05 was considered to be statistically significant.
The primary statistical analysis for proteomic data
focused on mitochondrial proteins only, as extracted from
DAVID based on GO:0005739. Signal intensities of the
mitochondria-associated proteins involved calculations
with two-way ANOVA using the MultiExperiment Viewer:
http://www.tm4.org/mev/ (Saeed et al, 2003). Results of the
two-way ANOVA are presented within functional categories
(DAVID, Uniprot) along with the F-ratio for each factor of
each protein found to have an F-ratio greater than the
critical value of 7.77 (P<0.01) with respect to APOE
genotype, global ischemia or their interaction. A conserva-
tive probability was selected to reduce the rate of identifying
false positives, but was relaxed slightly for network analysis
(see below). Protein functions were determined primarily
from annotations in Uniprot (http://www.uniprot.org/) and
DAVID protein databases. For indicative purposes, selected
biologically relevant proteins including human ApoE found
to differ significantly by two-way ANOVA are presented
with accompanying histograms along with results of post
hoc comparisons using t-test with Bonferroni correction.
Network Analysis
Three separate data sets containing only proteins consid-
ered to be significantly affected by a given factor (APOE
genotype, global ischemia, or their interaction) with F-ratio
values > 4.24 were uploaded with their corresponding
P values to Ingenuity Pathway Analysis (IPA) software.
Protein identifiers were mapped to corresponding objects
R2 = 0.9916
0
10
20
30
40
50
60
0
ADH [fmol]
M
ax
Qu
an
t i
nt
en
si
ty
 x
 1
06
500400300200100
Figure 1 Validation for the use of MaxQuant as a label-free
analysis tool. Quantitation of relative protein abundance using
MaxQuant was validated by spiking alcohol dehydrogenase
(ADH Saccharomyces cerevisiae, Sigma) into 10mL HeLa cell
extracts. A linear fit showed a correlation of spiked ADH
concentrations with the protein group intensity computed by
MaxQuant, with an R2 value of 0.992.
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in Ingenuity’s Knowledge Base. Networks were algorithmi-
cally generated based on direct relationships (physical
interaction) between eligible proteins. The shading of
network objects is negatively correlated with their P value.
IPA generates a score which is putatively a measure of
probability (but see Deighton et al, 2010 for critical
analysis) for the network.
Results
Integrity of Mitochondrial Fractions
Mitochondrial markers (VDAC1, COXI, and COXIV)
were used to determine the enrichment of mitochon-
drial proteins in mitochondria fractions isolated
from hippocampal tissue of APOE transgenic mice
as well as their absence in postmitochondrial frac-
tion supernatants (Figure 2A). VDAC1 is an outer
mitochondrial membrane protein involved in meta-
bolite diffusion, while both COXI and COXIV
are components of the electron transport chain,
located within the inner mitochondrial membrane.
All three antibodies show presence of mitochondrial
proteins in the enriched fraction. There was no
significant effect of either ischemia or genotype on
the percentage of VDAC1, COXI, or COXIV in the
mitochondrial fraction (Figure 2B). None of these
proteins were found in the postmitochondrial
fractions. These data indicate there has been
minimal breakdown of mitochondrial membranes
during fractionation, and neither ischemia nor APOE
genotype influence mitochondrial fractionation or
integrity.
Genotype-Dependent Increase in Hippocampal
Apolipoprotein E Levels of APOE-e4 Transgenic Mice
After Transient Global Ischemia
Levels of full-length ApoE were measured by
immunoblot in mitochondria-enriched fractions
prepared from the hippocampus by immunoblot in
shams and after ischemia. There were similar levels
of ApoE in sham APOE-e3 and APOE-e4 mice.
However in response to ischemia, there was a
marked increase in ApoE levels in APOE-e3 and
APOE-e4 transgenic mice (Figure 3). The levels of
ApoE were significantly greater in APOE-e4
as compared with APOE-e3 mice after ischemia.
Two-way ANOVA yielded a main effect for trea-
tment (F(1, 25) = 14.30, P<0.001) and genotype
(F(1, 25) = 5.49, P<0.05). No interaction effect was
observed (F(1, 25) = 3.02, P>0.05). Post hoc compar-
isons identified that ApoE levels were significantly
higher in APOE-e4 mice with ischemic injury
(2.5-fold higher) than in sham-operated APOE-e4
mice (P<0.001).
COXIV 20
15
kDa
VDAC1 40
30
kDa
COXI
25
37
kDa
ApoE3
Sham
ApoE3
Global
Ischemia
ApoE4
Global
Ischemia
ApoE4
Sham
VDAC1
ApoE3 ApoE4
0
50
100
150
%
VD
AC
COX1
ApoE3 ApoE4
0
50
100
150
%
 C
O
XI
COXIV
ApoE3 ApoE4
0
50
100
150
sham sham global
ischemia
%
 C
O
XI
V 
 
Relative Protein Levels:
M vs. PM fractions
PMMPMMPMMPMM
global
ischemia
Figure 2 Mitochondrial integrity of fractions. (A) Representative images of VDAC1, COX1, and COX1V immunoblots of sham and
global ischemia apolipoprotein E (APOE)-e3 and APOE-e4 hippocampal tissue. The hippocampus of each was fractionated into
mitochondrial (M) and postmitochondrial supernatant (PM) fractions. Mitochondrial proteins are detected in the mitochondrial
fraction only as evident by detection of outer membrane marker VDAC1 or inner membrane markers COXI and COXIV. (B) The
percentage of VDAC1, COXI, and COXIV measured in immunoblots in the mitochondrial fraction as compared with postmitochondrial
fraction was calculated. Two-way analysis of variance (ANOVA) determined no significant effect of either treatment or APOE
genotype.
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Ischemic Neuronal Damage in the Hippocampus
The percentage of ischemic neuronal damage
was assessed within the CA1 region of the hippo-
campus. In all sham-operated APOE-e3 and APOE-e4
transgenic mice, there was no ischemic neuronal
damage. Transient global ischemia for 20minutes
led to minimal neuronal damage in the hippocampus
of APOE-e3 and APOE-e4 transgenic mice (APOE-e3
1.5±1.0%, APOE-e4 1.6±1.2% ischemic neuronal
damage), with no significant difference between
genotypes (P=0.50). The low level of histological
damage in the study limits definitive exploration of
genotype influences (see Horsburgh et al, 2000b).
Quantitative Proteomic Analysis of Mitochondria-
Enriched Fractions
Using Maxquant software as a protein clustering and
validation tool, and assuming a false positive rate
of 0.01 based on a decoy database search, a total of
1,283 proteins were identified across all four groups,
and of this, 1,067 were identified with a minimum
of 2 peptides, the criterion for analytical inclusion
(see Supplementary Table 1 for full list of proteins).
LC-MS confirmed that human ApoE levels were
significantly higher in mitochondrial fractions from
APOE-e4 transgenic mice after global ischemia
(Figure 4). There was a significant effect of global
ischemia on ApoE levels (F(1, 25) =4.798, P<0.05)
and a significant difference between APOE-e4 mice
with ischemic injury and sham-operated APOE-e4
mice (P<0.05), whereas in both sham groups ApoE
was undetectable.
In all, 274 proteins were identified as mitochondria
associated based on the GO designation mitochon-
drion, from the 1,067 analyzed using DAVID software
(see Supplementary Table 2 for full list of mitochon-
drial proteins). This distribution of mitochondrial
versus nonmitochondrial proteins is in agreement
with other published studies using similar mitochon-
drial preparations (Forner et al, 2006). The categoriza-
tion based on function and subcellular localization as
determined by DAVID analysis for all the proteins
identified is shown in Figure 5 along with the
functional annotation of the mitochondrial proteins.
In all, 12 of the 274 mitochondrial proteins were
significantly altered (two-way ANOVA; P<0.01) in
relation to APOE genotype (two proteins: ETFA and
ATP6V1A), global ischemia (five proteins: NDUFB5,
CYB5B, HSPA1B, GLUL, and PHYHIPL), and inter-
action (five proteins: NDUFA11, NDUFS3, ATP5J,
OXR1, and IARS2). Functional categorization of
these proteins show a bias toward identifying
changes in proteins involved in oxidative phosphor-
ylation and stress (see Table 1).
Illustrative changes for some proteins found to
have relevance to ischemia are shown in Figure 6
(Chan et al, 1998; Kelly et al, 2001). For example,
marked increases in HSPA1B (HSP70) were observed
in APOE-e3 and APOE-e4 mice after global ischemia.
OXR1 was reduced in APOE-e4 with global ischemia,
but was not significantly different in APOE-e3 mice.
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Figure 3 Full-length ApoE protein is increased in mitochondrial
fractions after global ischemia. Full-length apolipoprotein E
(ApoE) was detected in immunoblots of mitochondria prepared
from the hippocampus of APOE transgenic mice after global
ischemia (APOE-e3 n=9; APOE-e4 n=9) or in sham-operated
controls (APOE-e3 n=5; APOE-e4 n=6). ApoE is present as a
doublet at 34 kDa. ApoE protein expression levels were
quantified. Post hoc comparisons showing statistical signifi-
cance are shown. ***P<0.001.
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Figure 4 Liquid-chromatography mass spectrometry (LC-MS)
detected increased apolipoprotein E (ApoE) protein intensity
levels in mitochondrial fractions after global ischemia. ApoE was
detected using LC-MS in mitochondria prepared from the
hippocampus of APOE transgenic mice after global ischemia
(APOE-e3 n=9; APOE-e4 n=9) or in sham-operated controls
(APOE-e3 n=5; APOE-e4 n=6) using LC-MS. There was a
significant effect of global ischemia. Post hoc comparisons
showing statistical significance are shown. *P<0.05.
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Certain patterns of protein expression are indicative
of differential regulation in response to ischemic
injury as a function of genotype.
Ingenuity Pathway Analysis Network Analysis
IPA, applied judiciously, allows the synthesis of
protein interactions from expansive protein lists and
facilitates a better understanding of complex biolo-
gical systems based on the creation of interactome
networks. IPA network analysis was performed on
three protein data sets referred to as APOE genotype,
global ischemia, and interaction (Table 1) and
comprising proteins with F-ratio values greater than
the critical value of 4.17 (P<0.05) and included 14,
18, and 27 proteins, respectively. Each network was
scored and attributed functions (see Figure 7B).
The APOE genotype network (IPA score= 23),
generated from 14 proteins, was attributed the
functions of ‘cellular compromise, genetic disorder,
and neurologic disease.’ The APOE genotype network
included ETFA as a major hub protein as well as
inner membrane components of complex 1 (NDUFB5
and NDUFB10), but required the insertion of multiple
MT-ND family members as well as the hub proteins
SNCA and HTT to allow for cohesion. The IPA score
was substantially lower than the other 2 networks.
The global ischemia network (IPA score = 31),
generated from 17 proteins, was attributed the
functions of ‘cellular growth and proliferation,
embryonic development and cell death.’ The
global ischemia network included HSP1AB as a
major hub protein and included multiple proteins
involved in oxidative stress (e.g., PRDX1, SOD1, and
HSPA1B).
The interaction network (IPA score = 33), generated
from 25 proteins, was attributed the functions
of ‘cardiovascular disease, genetic disorder, neuro-
logic disease.’ The interaction network had the
highest IPA score and like the genotype network
includes components of complex 1, albeit different
NDUF family members (NDUFA11 and NDUFS3),
that appear to make up the core of the functional
interactions. Distinct to this network are the ‘peri-
pheral’ proteins that are involved in various meta-
bolic roles that are lacking in the other networks
(e.g., DLAT, IVD, and ACADL).
Overall, in terms of significantly modulated mito-
chondrial proteins (Table 1), the effect of global
ischemia had a slightly larger effect on mitochondria
than APOE genotype. Moreover, after global ische-
mia, of those mitochondria-associated proteins
found to be significantly altered within a given
cohort, 73% are found to increase in APOE-e3 trans-
genic mice compared with basal levels while only
19% are increased in APOE-e4 mice (Figure 7A),
indicating that mitochondria in APOE transgenic
mice are responding differently to the stress of
ischemic injury.
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Figure 5 Functional annotation of all identified proteins as well as mitochondrial proteins across all four cohorts. Functional
groupings of identified proteins based on Database for Annotation, Visualization and Integrated Discovery (DAVID) analysis are
shown in the top pie chart. Of the 1,067 proteins uploaded to DAVID, the largest functional category, including 274 proteins, was
identified as mitochondrion. Further DAVID analysis of these 274 proteins is shown in the lower pie chart with the majority of
identified proteins localized to the inner membrane.
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Table 1 Altered mitochondrial proteins
IPI Gene name F-ratio
(genotype)
F-ratio
(global ischemia)
F-ratio
(interaction)
Protein function
Oxidative phosphorylation/tricarboxylic acid cycle
IPI00318645 Ndufa11 2.06 3.13 19.75 Complex I subunit
IPI00132531 Ndufb5 5.69 8.07 0.12 Complex I subunit
IPI00121288 Ndufb10 4.33 0.00 1.91 Complex I subunit
IPI00121309 Ndufs3 0.55 3.02 8.90 Complex I subunit
IPI00129516 Uqcrh 0.16 0.42 4.55 Complex III subunit
IPI00111885 Uqcrc1 0.73 4.70 0.89 Complex III subunit
IPI00114377 Cox7a2 0.87 0.38 5.60 Complex IV subunit
IPI00230507 Atp5h 1.26 0.59 7.34 Complex V subunit
IPI00125460 Atp5j 0.00 0.12 7.88 Complex V subunit
IPI00453777 Atp5d 2.11 0.12 4.69 Complex V subunit
IPI00315794 Cyb5b 1.10 8.98 2.53 Electron transport
IPI00116753 Etfa 10.33 0.55 1.84 Electron transport
IPI00261627 Sucla2 5.01 1.28 0.33 Tricarboxylic acid cycle enzyme
IPI00323592 Mdh 0.55 4.69 3.48 Tricarboxylic acid cycle enzyme
IPI00230754 Slc25a11 5.07 0.56 0.14 Carrier protein
Reactive oxygen species control/oxidative stress
IPI00660262 Gpx4 0.10 0.98 5.94 Antioxidant
IPI00121788 Prdx1 0.03 6.85 0.57 Antioxidant
IPI00130589 Sod1 0.08 4.39 4.70 Antioxidant
IPI00117929 Oxr1 5.80 7.64 14.79 Protects from oxidative damage
IPI00319518 Lonp1 6.44 4.36 0.16 Proteolysis of oxidized proteins
IPI00346073 Hspa1b 0.74 24.26 0.74 Chaperone protein
IPI00229080 Hsp90ab1 2.04 5.94 0.41 Chaperone protein
Other metabolic processes
IPI00626790 Glul 1.68 13.02 1.65 Glutamate metabolism
IPI00132593 Gls2 1.04 0.02 4.40 Glutamine catabolism
IPI00154047 Hibch 5.15 2.22 6.92 Amino-acid metabolism
IPI00116222 Hibadh 5.63 0.59 0.47 Amino-acid metabolism
IPI00227773 Ppp1cc 0.01 3.16 5.30 Glycogen metabolism
IPI00750256 Ak1 0.36 5.33 2.53 ATP/ADP interconversion
IPI00221769 Ak3 4.10 3.02 6.14 AMP phosphorylation
IPI00453499 Iars2 1.41 1.68 7.86 Protein synthesis
Lipid metabolism
IPI00119114 Acadl 0.33 0.00 4.25 Lipid metabolism
IPI00154054 Acat 5.11 0.44 2.31 Lipid metabolism
IPI00468653 Pccb 5.36 5.36 5.85 Lipid metabolism
Apoptosis
IPI00404551 Ctsd 1.85 6.46 1.80 Protease/Apoptosis
Protein import
IPI00134484 Timm13 2.07 6.38 0.00 Small transporter inner membrane complex
IPI00165902 Timm10 2.96 0.39 5.73 Small transporter inner membrane complex
Mitochondrial transport
IPI00515349 Rhot1 5.09 0.69 2.22 Attachment to microtubules
IPI00473646 Rhot2 2.16 3.20 4.31 Attachment to microtubules
Unknown mitochondrial function
IPI00115827 Gbas 0.09 1.37 5.50 NipSnap family/vesicular transport
IPI00407692 Atp6v1a 8.14 0.14 0.01 Subunit of V-ATPase/proton transport
IPI00648312 Nt5dc3 2.37 1.79 6.77 ?
IPI00224093 Phyhipl 2.07 14.02 2.07 ? Central nervous system development
IPI00655156 Ccdc109a 4.75 1.15 1.40 Coiled-coil domain family
IPI00331549 Dhrs1 1.33 4.82 0.66 Oxidoreductase
IPI00135106 Mobp 1.60 0.08 7.30 Myelin sheath stability
IPI00131614 Sncb 0.85 0.03 5.59 ? Neuronal plasticity
IPI00131896 Brp44 0.04 0.09 4.41 ?
IPI00153792 Qil1 0.16 0.04 4.94 ?
The critical values F (1, 25) for P<0.01 and P<0.05 are 7.77 and 4.24, respectively. Of the 275 mitochondrial proteins, 12 presented here have F values
>7.77 in respect to genotype (2), global ischemia (5), or their interaction (5). All mitochondrial proteins with an F value >4.24 for at least one comparison
are included in the table and highlighted in bold. Proteins are presented in functional categories as they relate to mitochondrial function.
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Discussion
The present study demonstrates that not only are the
levels of ApoE increased to a greater extent in
mitochondria of APOE-e4 mice as compared with
APOE-e3 mice, after an ischemic challenge, but that
there are clear APOE genotype differences in the
proteomic response of mitochondria in response to
this challenge. The study additionally highlights
that, even in the absence of injury, the proteomic
signature is different between APOE genotypes.
ApoE isoform effects were investigated in response
to a transient ischemic insult, which results in selective
and delayed neuronal degeneration. In the mouse
model used in this study and others (Horsburgh et al,
2000b; Kelly et al, 2001), there is a regional hierarchy
of damage such that the striatum exhibits a greater
extent of damage as compared with the hippocampus.
The extent of damage can be influenced by a number
of variables notably, the duration of ischemia, temp-
erature, and anesthetic. In the current study, in the
hippocampus we detected minimal neuronal damage
in response to transient global ischemia. Thus,
our results reflect the hippocampal mitochondrial
response in APOE transgenic mice to ischemic injury,
and not overt neuronal cell death, with mitochondrial
dysfunction a likely consequence of the ischemic
insult. This work builds on our previous studies in
which we demonstrated that ApoE levels are markedly
increased in neurons in response to a severe ischemic
injury with ApoE levels being greatest in APOE-e4
compared withAPOE-e3 transgenic mice. This increase
in ApoE parallels the more extensive hippocampal
damage in APOE-e4 as compared with APOE-e3 mice
in response to injury, suggesting that the increase
in ApoE4 may be contributing to the cell death
(Horsburgh et al, 2000b). In the present study, the
marked elevation of ApoE levels in mitochondria may
be important to the pathogenic effect of ApoE4.
Previous studies have indicated structural and
subsequent biophysical differences between ApoE
protein isoforms which may explain differential
influences on mitochondrial function (Huang et al,
2004). The present study sought to identify whether
the protein signature is different between APOE
genotypes in the presence and absence of injury.
We used mass spectrometry-based proteomic tech-
niques that offer a powerful approach to identify
and quantify proteins in a complex mixture. Label-
free quantification requires neither prior knowledge
nor labelling strategy, and protein expression is
determined from peptide intensities (Ong and Mann,
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Figure 6 Protein intensity levels of selected mitochondrial proteins significantly modulated as a result of global ischemia,
apolipoprotein E (APOE) genotype, or both. Normalized peptide protein intensity levels of selected proteins across all four experimental
cohorts are indicative of differential protein regulation. Post hoc comparisons are shown. *P<0.05, **P<0.01, ***P<0.001.
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2005; Stewart et al, 2004; Wang et al, 2003). The ADH
spiking experiments (see Figure 1) validate the use of
MaxQuant to quantitate relative protein abundance
in our hippocampal fractions without the use of
isotope labelling. Using this technique, we were able
to identify 274 mitochondria-associated proteins
from a total of 1,067 proteins identified with at least
two peptides. Based on recent work suggesting there
are 1,075 mitochondrial proteins in brain (Kislinger
et al, 2006), we have identified B26% of the
‘complete’ mitochondrial proteome based on current
GO annotation. Given our experimental design, with
each sample subjected to a single round of LC-MS, in
contrast to more comprehensive interrogations of
the mitochondrial proteome (Kislinger et al, 2006;
Mootha et al, 2003), which typically use repli-
cate analysis of the same sample or more complex
protein fractionation methods before LC-MS analy-
sis, we have detected a reasonable percentage of
the mitochondrial proteome. Furthermore, the detec-
tion of human ApoE at levels that are reminiscent of
earlier observed differences in ApoE levels within
E3S vs E3G 
Up
Down
E4S vs E4G
73%
27%
33 Interaction 
31 Global Ischemia 
23 ApoE Genotype 
IPA Score Factor 
19%
81%
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Interaction
Global
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Figure 7 (A, B) Apolipoprotein E (APOE) genotype differential regulation of mitochondrial protein expression after global ischemia.
(A) The percentage of upregulated and downregulated proteins in ApoE3 and ApoE4 transgenic mice after global ischemia (G) versus
sham (S) indicates a differential regulation of protein levels. IPA network analysis was completed with proteins whose differential
expression was a result of APOE genotype, global ischemia, or their interaction as determined by two-way analysis of variance
(ANOVA). All proteins with an F-ratio value >4.24 within a given category were included. Network scores are indicative of a more
robust fit to a given network. (B) The top networks from each data category are presented. Blue shaded nodes are those proteins
uploaded to IPA, whereas unshaded nodes have been inserted by IPA to create a network with a maximum number of 35 molecules.
Only those molecules with direct relationships (physical interaction) indicated by solid edges were included in the analysis.
IPA, Ingenuity Pathway Analysis.
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the immunoblot data lend credence to the use of
label-free quantification techniques not only to
identify proteins, but do so in different biological
contexts, i.e., an ischemic challenge. In the present
study, the largest functional category was identified
as mitochondrion but other categories were identi-
fied including the cytoskeleton and synapse. ApoE is
reported to have diverse roles within the central
nervous system including regulation of synaptic
plasticity and these other functions could be studied
further using the present approach by isolation of
different cellular compartments (e.g., synapses).
Our proteomic results show that under basal and
injury conditions, APOE genotype has a differential
effect on mitochondrial protein levels indicative of
significant alterations in the regulation of energy
production, metabolism, redox control/oxidative
stress, and organelle dynamics (Table 1). One of the
primary functions of mitochondria is energy produc-
tion, with glucose the primary fuel for the brain.
Glucose is converted into ATP via a number of
metabolic reactions encompassing glycolysis, the
pyruvate dehydrogenase complex, and tricarboxylic
acid cycle, before oxidative phosphorylation and the
subsequent generation of ATP. Although glycolysis
generates ATP under basal conditions, and in
particular in times of cellular stress, oxidative
phosphorylation is the most efficient means of ATP
production (Magistretti and Pellerin, 1999); and
therefore, neuronal function is critically dependent
on oxidative phosphorylation, which itself is depen-
dent on the efficient functioning of various metabolic
pathways. In the present study, we were able to
demonstrate that the isolated mitochondria remained
relatively intact after cerebral ischemia as compared
with those from control tissue allowing the identifi-
cation of their proteomic signature. Within the
isolated mitochondria, we were able to detect even
small molecules (including cytochrome C) although
these were not found to be significantly altered
across the cohorts. In response to ischemia, it is
recognized that dynamic alterations occur within
mitochondria resulting in generation of reactive
oxygen species and release of proteins such as
cytochrome C and Smac, alterations in which we
would not be able to detect in the preparation used
(for review, see Niizuma et al, 2010). Although we
cannot directly correlate expression levels with
enzyme activity, assumptions can be made of the
functional capacity of the affected mitochondria.
Approximately the same number of proteins, albeit
distinctly different proteins, categorized as being
functionally involved in oxidative phosphorylation,
are affected by genotype, global ischemia, or interac-
tion as seen in the respective data sets in Table 1. The
lack of congruency is suggestive of differential
regulation of key inner mitochondrial proteins. For
example, NDUFA11 is increased in APOE-e3 mice
after global ischemia (see Figure 6), but is decreased
in APOE-e4 after the same insult, leading to a
relatively high F-ratio (19.75) for the interactive effect
of both genotype and ischemia on this component of
complex 1 of the electron transport chain (P<0.01).
Various other proteins located within the inner
mitochondrial membrane were also found to be
significantly modulated across the groups. Many of
these, like NDUFA11 are found within the electron
transport chain (e.g., NDUFB5, NDUFB10, and
COX7A2) and are major components of the genotype
and interaction functional networks (Figure 7B).
Others are involved in protein/ion transport across
the inner membrane (e.g., TIMM10, TIMM13, and
SLC25A11; Lutz et al, 2003; Iacobazzi et al, 1992) and
are differentially expressed across the different
cohorts in similar ways. These data may suggest that
the inner mitochondrial dynamics of the two geno-
types are fundamentally different. Increased expres-
sion of a truncated form of ApoE4 associated with
mitochondrial dysfunction (Chang et al, 2005) has
been shown to reduce the activities of complex III
and IV of the inner mitochondrial membrane (Naka-
mura et al, 2009), and likewise, we see differential
regulation of proteins that represent both complexes
(e.g., UQCRH and Cox7a2, respectively).
Unsurprisingly, after the ischemic challenge, both
APOE-e3 and APOE-e4 mice show modulation of
proteins involved in oxidative stress, including
HSPA1B (or HSP70), SOD1, OXR1, and PRDX1
(Kelly et al, 2001; Hwang et al, 2010; Chan et al,
1998) but alterations in these proteins were APOE
genotype dependent. For example, OXR1 which
protects against oxidative damage and has been
shown to be induced after oxidative stress (Elliott
and Volkert, 2004), is increased in APOE-e3 mice
after ischemia but is downregulated after ischemia in
APOE-e4 mice (see Figure 6). Similarly, PRDX1 was
significantly increased in the APOE-e3 mice after
global ischemia, whereas no such change was seen in
the APOE-e4 mice. This may suggest a decreased
capacity to respond to oxidative damage under basal
conditions (increased expression in sham-operated
APOE-e4 compared with APOE-e3 mice), with less
effective protection afforded after ischemic injury
(decreased expression in APOE-e4 ischemic com-
pared with sham mice). This is reflected in the global
ischemia functional network as well, which com-
prising multiple proteins implicated in the cellular
response to global ischemia and attributed the
associated function of ‘cell death.’
Various metabolic proteins were also found to be
altered, some of which can be found within the
interaction functional network (Figure 7B) as ‘peri-
pheral’ nodes (e.g., PCCB, ACADL, and ACAT) and are
involved in different facets of lipid metabolism vital
for normal cell functioning. Other proteins (GLUL,
HIBCH, AK1, and AK3) are involved in different
aspects of energy metabolism. This suggests thatAPOE
genotype has an effect on the metabolic capacity of the
mitochondria after ischemia, which in turn may have
downstream effects on ATP production.
IPA networks also indicated certain molecules that
are potentially involved in the regulatory control of
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proteins that were found to be upregulated and
downregulated as a result of either genotype or
ischemia. This includes the transcription factor
HNF4A, which appears in all three generated net-
works. This molecule as well as other inserted nodes
allow for the generation of new hypothesis pertain-
ing to mechanisms underlying pathology as well as
how to potentially intervene.
Besides the efficient production of ATP by
individual mitochondria, the proper distribution of
mitochondria along the neuron is important to
provide local ATP supplies as well as buffer calcium
transients in both the synapse and dendrite (Cai and
Sheng, 2009; Ly and Verstreken, 2006). Therefore,
the efficient transport of mitochondria along the
neuronal cytoskeleton is critical. Disturbances to
mitochondrial motility can impact on neuronal
energy demands and viability (Rintoul and Reynolds,
2010), which are shown to be disturbed in APOE
transgenic mice (Tesseur et al, 2000). RHOT1 and
RHOT2 are two modulated proteins (genotype
and interaction, respectively) identified with invol-
vement in mitochondrial transport (Koutsopoulos
et al, 2010; Misko et al, 2010; Russo et al, 2009).
These changes may also have relevance to under-
standing potential apoE isoform differences in regula-
ting aspects of synaptic plasticity.
Proteomic analysis has allowed us to identify
functional pathways that are likely more susceptible
to dysfunction in the context of a particular APOE
genotype. Future studies could also elucidate
whether the association between ApoE and mito-
chondria is direct or mediated through a secondary
interaction, and if ApoE can translocate across the
mitochondrial membrane. Additionally, it remains to
be determined whether increases in ApoE levels or
isoform are the main contributor to the pathogenic
effect of ApoE4 after injury. Irrespective of this, the
present study provides a basis on which to allow for
further exploration into the mechanisms behind the
differential regulation of mitochondrial function by
ApoE isoforms.
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